Relapse of herpes simplex encephalitis in children

Area of Science:

• Pediatric Neurology
• Infectious Diseases
• Molecular Diagnostics

Background:

• Herpes simplex encephalitis (HSE) is a severe neurological condition in children.
• Early and accurate diagnosis is crucial for effective treatment and improved outcomes.
• Current diagnostic methods may have limitations in speed and sensitivity.

Purpose of the Study:

• To evaluate the utility of polymerase chain reaction (PCR) assay for the early diagnosis of HSE in pediatric patients.
• To compare the diagnostic timing of PCR with antibody detection methods.
• To investigate the role of PCR in monitoring viral presence and understanding disease relapse.

Main Methods:

• Cerebrospinal fluid samples from 15 children diagnosed with HSE were analyzed.
• Polymerase chain reaction (PCR) assay was used to detect herpes simplex virus (HSV) DNA.
• Enzyme-linked immunosorbent assay (ELISA) was employed to detect intrathecally produced anti-HSV antibodies.

Main Results:

• All 15 initial cerebrospinal fluid samples were positive for HSV DNA by PCR.
• PCR assay detected HSV DNA significantly earlier than anti-HSV antibodies (4.4 vs 8.9 days post-onset).
• HSV DNA persisted in cerebrospinal fluid for 3-18 days; relapses occurred in 4 patients, with temporary reappearance of HSV DNA in 2.

Conclusions:

• Polymerase chain reaction (PCR) assay is a valuable tool for early, noninvasive diagnosis of herpes simplex encephalitis in children.
• The early detection of HSV DNA by PCR facilitates timely intervention.
• Shorter acyclovir therapy duration may be associated with an increased risk of HSE relapse in some children.